0 Views
0 Likes
0 Shares
0 Comments
Read article ↗

StayCurrentMD

View profile →

Article

Long-Term Reduction of Liver Fibrosis Surrogates in Syndromic Biliary Atresia

Published: Reading: 1 min

Topic overview

This study examines long-term liver fibrosis outcomes in patients with Biliary Atresia Splenic Malformation syndrome (BASM) following Kasai portoenterostomy. Despite similar initial surgical responses, BASM patients demonstrate reduced liver fibrosis markers over extended follow-up compared to isolated biliary atresia cases.

Key takeaways

  • BASM patients show reduced liver fibrosis progression compared to isolated BA despite similar initial Kasai response
  • Long-term fibrosis surrogates differ between syndromic and non-syndromic biliary atresia phenotypes
  • Congenital anomalies in BA may predict better hepatic fibrosis outcomes post-Kasai portoenterostomy

Keywords

Biliary Atresia Kasai Portoenterostomy Liver Fibrosis Basm Syndrome Pediatric Hepatology Congenital Anomalies

Hashtags

#BiliaryAtresia #PediatricHepatology #LiverFibrosis #KasaiProcedure

Full article text

Full article text not available for this entry
How to cite: GlobalCastMD. Long-Term Reduction of Liver Fibrosis Surrogates in Syndromic Biliary Atresia. GlobalCastMD Medical Library. 2025-09-01. https://library.globalcastmd.com/article/11255

Comments

Loading comments...